Clinical Study
Restoration of Innate and Adaptive Immune Responses by HCV Viral Inhibition with an Induction Approach Using Natural Interferon-Beta in Chronic Hepatitis C
Table 1
Characteristics of chronic hepatitis C with high viral load, serotype-1 (genotype 1b), and wild or intermediate type in ISDR before, during, and after RBV plus PEG-IFN-alpha 2b using an “induction” therapy with cyclic and periodic interferon treatment (CPIT); novel combination treatment (NCT).
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IFN: interferon, BMI: body mass index, ISDR: IFN sensitivity determining region, F: female, M: male, SBR: sustained biochemical response, NBR: no biochemical response, and TBR: transient biochemical response. |